UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017560
Receipt number R000020346
Scientific Title Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis C
Date of disclosure of the study information 2015/05/14
Last modified on 2015/05/14 13:23:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis C

Acronym

Study of the response of ribavirin monotherapy in patients with chronic hepatitis C

Scientific Title

Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis C

Scientific Title:Acronym

Study of the response of ribavirin monotherapy in patients with chronic hepatitis C

Region

Japan


Condition

Condition

Chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To study patients' and viral response during ribavirin monotherapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The effects of the combination therapy with interferon preceeded with ribavirin monotherapy.

Key secondary outcomes

Adverse events of ribavirin monotherapy.


Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

ribavirin monotherapy for 4 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Chronic hepatitis patients with anti-HCV and HCV-RNA positive

Key exclusion criteria

We excluded:
1)HBs antibody positive
2))HIV antibody positive
3)decompensated liver chirrosis
4)severe herat failuer
5)severe kideny dysfunction
6)ineligible to interferon therapy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuhei Hige

Organization

Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital

Division name

Department of 3rd Gastroenterolgy

Zip code


Address

North 3 Jo, East 8-5, Chuo-Ku, Sapporo

TEL

011-261-5331

Email

shuhei.hige@ja-hokkaidoukouseiren.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoe Kobayashi

Organization

Hokkaido University

Division name

Department of Gastroenterology

Zip code


Address

North 17 jo, West 5 chome, Kita-Ku, Sapporo

TEL

011-706-7429

Homepage URL


Email

tk990063@yahoo.co.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University, Department of Gastroenteroly

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

008-0046

Org. issuing International ID_1

Hokkaido University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 09 Month 09 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 14 Day

Last modified on

2015 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020346


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name